Where to find EY Life Sciences at BIO International Convention
5–7 June 2018 in Boston, MA
Rapid technological advances have made it possible to generate and disseminate data at unprecedented rates. As new technologies empower individuals to see and share their health data, they are demanding greater say over their lifelong health journey, as well as new health products and services. In this rapidly converging world, life sciences companies must consider how they will adapt and their current business models and how they will adapt to create future value.
Come hear our EY moderators and their distinguished panelists discuss the upside of this disruption including precision medicine, the rising expectations of stakeholders, the underlying drivers of consumer decision-making and more at BIO 2018, 5-7 June in Boston, MA.
Who you’ll see from EY at BIO 2018
The following BIO 2018 panels will be moderated by EY leaders. Click on each EY leader to learn more
EY’s global life sciences leader will be at BIO taking part in various networking events, meeting the media and holding conversations centered on a key question. How can tech help biotech fuse the physical, digital and biological worlds?
Precision medicine coming of age
Biotechnology financing, dealmaking and state of the industry: findings from EY industry analysis
What’s really driving your customer’s behavior? How cutting edge biopharmas are using behavioral economic frameworks to reach patients in a digital world
Is your growth strategy a big deal? Maximizing shareholder value in today’s high valuation environment
Drawing a line in the sand: rethinking pharmacy benefits
Digital transformation in the life sciences
Adlai Goldberg (speaker)
Download our reports to learn more about current Life Sciences conversations.